ZA757067B - Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones - Google Patents

Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones

Info

Publication number
ZA757067B
ZA757067B ZA757067A ZA757067A ZA757067B ZA 757067 B ZA757067 B ZA 757067B ZA 757067 A ZA757067 A ZA 757067A ZA 757067 A ZA757067 A ZA 757067A ZA 757067 B ZA757067 B ZA 757067B
Authority
ZA
South Africa
Prior art keywords
pyran
dihydroxy
ones
substituted
pharmaceutical compositions
Prior art date
Application number
ZA757067A
Inventor
Lawrence William Chakrin
William Chakrin Lawrence
Kenneth Means Snader
Means Snader Kenneth
Cheste Rhodes Willis
Rhodes Willis Cheste
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of ZA757067B publication Critical patent/ZA757067B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA757067A 1974-11-11 1975-11-10 Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones ZA757067B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52283774A 1974-11-11 1974-11-11

Publications (1)

Publication Number Publication Date
ZA757067B true ZA757067B (en) 1976-11-24

Family

ID=24082586

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA757067A ZA757067B (en) 1974-11-11 1975-11-10 Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones

Country Status (8)

Country Link
AU (1) AU498774B2 (en)
BE (1) BE835266A (en)
CA (1) CA1057661A (en)
DE (1) DE2550647A1 (en)
FR (1) FR2290197A1 (en)
GB (1) GB1529463A (en)
IE (1) IE43594B1 (en)
ZA (1) ZA757067B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153720A (en) * 1978-01-19 1979-05-08 Smithkline Corporation 3-Acyl-5-alkyl-2H-pyran-2,4,6-(3H,5H)-triones and their 4-hydroxy tautomers
DK277585A (en) * 1984-07-06 1986-01-07 Lonza Ag STABILIZER MIXTURES FOR VINYL CHLORIDE POLYME MASSES

Also Published As

Publication number Publication date
FR2290197A1 (en) 1976-06-04
IE43594L (en) 1976-05-11
CA1057661A (en) 1979-07-03
DE2550647A1 (en) 1976-05-20
IE43594B1 (en) 1981-04-08
BE835266A (en) 1976-05-05
GB1529463A (en) 1978-10-18
AU8631275A (en) 1977-05-12
FR2290197B1 (en) 1978-07-28
AU498774B2 (en) 1979-03-22

Similar Documents

Publication Publication Date Title
KE3052A (en) Pharmaceutical compositions
ZA74385B (en) Pharmaceutical compositions
IL46959A0 (en) 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them
ZA755998B (en) Pharmaceutical compositions
IL48508A0 (en) New pharmaceutical compositions comprising piperidylindole derivatives
AU487061B2 (en) Pharmaceutical compositions
IL48360A0 (en) Pharmaceutical compositions comprising a certain 1,3-bischromonyloxypropane derivative
MY8100372A (en) Pharmaceutical compositions
ATA392274A (en) 2,6-dialkoxybenzamides
NZ179502A (en) Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition
IL46476A0 (en) 2-substituted 4,5-diphenylthiazoles,their preparation and pharmaceutical compositions containing them
NZ179530A (en) 9-aminoalk(en)yl-9,10-dihydro9,10-methanoanthracenes and pharmaceutical compositions
IL46409A (en) 7,8-dihalo-1,2,3,4-tetrahydro-isoquinolines their preparation and pharmaceutical compositions containing them
IL49344A (en) 2-substituted-7-halo-1,8-maphthyridine compounds,processesfor preparing the same and pharmaceutical compositions containing the same
GB1520905A (en) 1,3,4-thiadiazole-2-ylureas
ZA755802B (en) Pharmaceutical compositions
IL48527A0 (en) New 7,7-diphenyl-hexahydro-1,4-oxazepines,their manufacture and pharmaceutical compositions containing them
ZA757067B (en) Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones
PH12855A (en) Pharmaceutical compositions
MY7900033A (en) Pharmaceutical compositions
NZ178737A (en) 4a-aryl-trans-decahydroisoquinolines, and pharmaceutical compositions containing such
IL47263A (en) 3s-methyl-7-nitro-5-phenyl-2h-1,4-benzodiazepine-2-ones, their manufacture and pharmaceutical compositions containinthem
IE41250B1 (en) 2,2-bis-hydroxymethylalkanesulphonates
NZ178646A (en) 2,3-dihydro-1-benzothiepin-4-carboxamides and pharmaceutical compositions
IL46670A0 (en) 1,2,4-triazolidin-3-ones